Form 4 for ATOS ATOSSA THERAPEUTICS, INC.
Accepted 2023-11-17 00:00:00 ET · period of report 2023-11-15 · accession 0001437749-23-032461 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-17 | 2023-11-15 | ATOS | WEAVER GREGORY L | CFO, Former EVP, Dir | S - Sale | $0.65 | -50.0K | 55 | -100% | -$32.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-15 | S | D | 50,000 | $0.65 | 55 | D | — | — |